CHU Brugmann

Futó vizsgálatok

• Toboroz

  Phase 3 Study of Azenosertib Versus Chemotherapy in Platinum-Resistant Ovarian Cancers Positive for Cyclin E1 Protein Expression

  2025-524641-27-00· 3. fázis· Forrás

• Még nem toboroz

  A Study to Assess Efficacy and Safety of Efgartigimod in Adults With Sjogren's Disease-associated Sensorimotor Polyneuropathy or Sensory Polyneuropathy (SERENITY)

  NCT07760818· 2. fázis· Forrás

• Toboroz

  Effect of Anti-Psoriatic Biologics on Risk of Anogenital Warts (CONDYPSO)

  NCT07234838· Forrás

• Toboroz

  Personalizing the Use of Pembrolizumab for Patients Who Have a Strong Response in Early Triple Negative Breast Cancer

  NCT06606730· 3. fázis· Forrás

• Fut, nem toboroz

  Controlled Interruption of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Infections

  NCT04779970· 2. fázis· Forrás

• Toboroz

  Benefits of a Renal Rehabilitation Program Adapted to Uremic Patients on Daily Hemodialysis at Low Dialysate Flow Rate.

  NCT07413315· Forrás

• Toboroz

  Better Understanding of Fatigue After STroke

  NCT06292377· Forrás

• Toboroz

  A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

  NCT06318169· 3. fázis· Forrás

• Fut, nem toboroz

  Efficacy and safety of conventional neoadjuvant therapy versus total neoadjuvant therapy in older patients with locally advanced rectal cancer: a multicentre, open-label, randomised pragmatic clinical trial

  2023-506703-26-00· 3. fázis· Forrás

• Toboroz

  Efficacy and Safety of Conventional Neoadjuvant Therapy Versus Total Neoadjuvant Therapy in Older Patients With Locally Advanced Rectal Cancer

  NCT06052332· Forrás

• Toboroz

  DESTINY Breast Respond HER2-(Ultra)Low Europe

  NCT05945732· Forrás

• Fut, nem toboroz

  A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

  NCT05757869· 3. fázis· Forrás

• Fut, nem toboroz

  Incidence of Graves' Disease After COVID-19 Vaccination

  NCT07213141· Forrás

• Toboroz

  A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

  NCT05431088· 2/3. fázis· Forrás

• Toboroz

  Prognostic Value of Cerebrospinal Fluid Immunoglobulin Free Light Chains in Patients With Multiple Sclerosis

  NCT05072691· Forrás

• Fut, nem toboroz

  A clinical trial to evaluate the safety and effectiveness of MGL-3196 (resmetirom) in patients with Non-Alcoholic Steatohepatitis (NASH) and reduce progression of liver damage and resolve NASH

  2024-510626-89-00· 3. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Krónikus vesebetegség1 toboroz
• Petefészekrák1 toboroz
• Pikkelysömör1 toboroz
• Sarlósejtes vérszegénység1 toboroz
• Sclerosis multiplex (SM)1 toboroz
• Sjögren-szindróma1 toboroz
• Stroke (szélütés)1 toboroz
• Tripla negatív emlőrák1 toboroz
• Vastagbélrák1 toboroz
• Zsírmáj (MASLD/MASH)1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Leállították

  A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy

  NCT06987968· 2. fázis· Forrás

• Lezárult

  A Phase 3, Double-blind Maintenance Study Assessing Rocatinlimab in Moderate-to-severe AD (ROCKET-ASCEND)

  NCT05882877· 3. fázis· Forrás

• Lezárult

  A study to evaluate if aticaprant added to a current antidepressant and given up to one year is safe and would help improve depression.

  2023-508163-74-00· 3. fázis· Forrás

• Lezárult

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· 3. fázis· Forrás

• Lezárult

  A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD)

  NCT05724199· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of the Efficacy, Safety, and Pharmacokinetics of a 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)

  NCT04657289· 3. fázis· Forrás

• Lezárult

  Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer

  NCT03778931· 3. fázis· Forrás